Inter Pharma PCL (BKK:IP)

Market Cap	3.36B +58.6%
Revenue (ttm)	2.24B +14.5%
Net Income	132.64M +186.0%
EPS	0.22 +186.0%
Shares Out	605.34M
PE Ratio	25.33
Forward PE	n/a
Dividend	0.07 (1.32%)
Ex-Dividend Date	May 6, 2026

Volume	446,870
Open	5.55
Previous Close	5.55
Day's Range	5.55 - 5.55
52-Week Range	3.14 - 5.65
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 64
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2025, Inter Pharma PCL's revenue was 2.21 billion, an increase of 15.80% compared to the previous year's 1.91 billion. Earnings were 122.38 million, an increase of 233.93%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 11, 2026

Data Sources Report a data error